Last Updated 20 May 2022.
5 Vaccines Approved for Use in France
-
Novavax
Nuvaxovid- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 37 countries
15 trials in 12 countries
Approval Source: ema.europa.eu
-
Moderna
Spikevax- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 86 countries
63 trials in 22 countries
Approval Source: ema.europa.eu
-
Pfizer/BioNTech
Comirnaty- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 146 countries
80 trials in 26 countries
Approval Source: ema.europa.eu
-
Janssen (Johnson & Johnson)
Ad26.COV2.S- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 111 countries
23 trials in 23 countries
Approval Source: ema.europa.eu
-
Oxford/AstraZeneca
Vaxzevria- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 140 countries
63 trials in 30 countries
Approval Source: ema.europa.eu
6 Vaccines in Clinical Trials in France
-
Sanofi/GSK
Recombinant Protein- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
6 trials in 7 countries
-
Sanofi/GSK
SP/GSK subunit B.1.351 vaccine- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
1 trial in 1 country
-
Sanofi/GSK
SP/GSK subunit D614 vaccine- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
1 trial in 1 country
-
Pfizer/BioNTech
Comirnaty- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 146 countries
80 trials in 26 countries
-
Janssen (Johnson & Johnson)
Ad26.COV2.S- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 111 countries
23 trials in 23 countries
-
ReiThera
GRAd-COV2- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
5 trials in 12 countries
2 Vaccines with Trials in France are No Longer Progressing
-
Curevac
CVnCoV- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
9 trials in 12 countries
-
Institut Pasteur
COVID-19-101- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 2 countries